Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
// Jinyan Liu 1, * , Feng Li 1, * , Yu Ping 1 , Liping Wang 2 , Xinfeng Chen 1 , Dan Wang 1 , Ling Cao 1 , Song Zhao 3 , Bing Li 3 , Pawel Kalinski 5 , Stephen H. Thorne 5 , Bin Zhang 6 , Yi Zhang 1, 2, 4 1 Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China 2 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China 3 Department of Thoracic surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China 4 Engineering Key Laboratory for Cell Therapy of Henan Province, Zhengzhou, Henan, P.R. China 5 Department of Surgery, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA 6 Robert H. Lurie Comprehensive Cancer Center, Department of Medicine-Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA * These authors have contributed equally to this work Correspondence to: Yi Zhang, e-mail: yizhang@zzu.edu.cn Keywords: esophageal squamous cell carcinoma, T lymphocyte, chemotaxis, CCL5, CXCL10 Received: April 01, 2015 Accepted: July 06, 2015 Published: July 16, 2015 ABSTRACT Esophageal squamous cell carcinoma (ESCC) is a very common malignant tumor with poor prognosis in China. Chemokines secreted by tumors are pivotal for the accumulation of CD8 + T lymphocytes within malignant lesions in several types of cancers, but the exact mechanism underlying CD8 + T lymphocyte homing is still unknown in ESCC. In this study, we revealed that, compared with marginal tissues, the expression of both chemokine (C-C motif) ligand 5 (CCL5) and (C-X-C motif) ligand 10 (CXCL10) was upregulated in ESCC tissues. CCL5 expression was positively associated with the overall survival of patients. Meanwhile, RT-PCR data showed that the expression of CCL5 and CXCL10 was positively correlated with the local expressions of the CD8 + T lymphocyte markers ( CD8 and Granzyme B ) in tumor tissues. Correspondingly, CD8 + T lymphocytes were more frequently CCR5- and CXCR3-positive in tumor than in peripheral blood. Transwell analysis showed both CCL5 and CXCL10 were important for the chemotactic movement of CD8 + T lymphocytes. Our data indicate that CCL5 and CXCL10 serve as the key chemokines to recruit CD8 + T lymphocytes into ESCC tissue and may play a role in patient survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825 · cited 1×
“Tumoral infiltration of cytolytic CD8+ T lymphocytes is associated with a favorable prognosis and increased survival [34–36].”
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Chemokines are small heparin-binding proteins weighing 8–14 kDa, which guide the migration of circulating lymphocytes to specific tissues [1].”
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 2×
“In cancer patients, the immune cell-infiltration is tightly associated with chemotaxis, and the numbers and types of lymphocytes recruited are determined by the local chemokines secreted [3].”
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment
Harlin, H., Meng, Y., Peterson, A. C., Zha, Y., Tretiakova, M., Slingluff, C., McKee, M., & Gajewski, T. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2281 · Cited by 1,121 · cited 2×
“CXCL10 is involved in the recruitment of CD8+ T lymphocytes in breast cancer [29], colorectal carcinoma [8], melanoma [28], and hepatocellular carcinoma [30].”
Djenidi, F., Adam, J., Goubar, A., Durgeau, A., Meurice, G., de Montpréville, V., Validire, P., Besse, B., & Mami-Chouaib, F. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402711 · Cited by 622
Oldham, K. A., Parsonage, G., Bhatt, R. I., Wallace, D. M. A., Deshmukh, N., Chaudhri, S., Adams, D. H., & Lee, S. P. (2012) · European Urology · doi:10.1016/j.eururo.2011.10.035 · Cited by 104 · cited 3×
“The CXCR3-CXCL10 interaction induces the infiltration of CD8+ T lymphocytes in renal cell carcinoma [4] and colorectal carcinoma [27].”
Cited by
Chow, M. T., Ozga, A. J., Servis, R. L., Frederick, D. T., Lo, J. A., Fisher, D. E., Freeman, G. J., Boland, G. M., & Luster, A. D. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.010 · Cited by 716
“In fact, other chemokine systems, such as CCR2, CCR5, CX3CR1, are associated with T cell migration into tumors (Ahrends et al., 2017; Berghuis et al., 2011; Chew et al., 2012; Fridman et al., 2012; González-Martı́n et al., 2011; Harlin et al., 2009; Liu et al., 2015; Mlecnik et al., 2010).”
Fates of CD8+ T cells in Tumor Microenvironment
Maimela, N. R., Liu, S., & Zhang, Y. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.11.004 · Cited by 459
Self-citationMigrating into the tumor: a roadmap for T cells
van der Woude, L. L., Gorris, M. A. J., Halilovic, A., Figdor, C. G., & de Vries, I. J. M. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.09.006 · Cited by 307
Karachaliou, N., Gonzalez-Cao, M., Crespo, G., Drozdowskyj, A., Aldeguer, E., Gimenez-Capitan, A., Teixido, C., Molina-Vila, M. A., Viteri, S., De Los Llanos Gil, M., et al. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017749748 · Cited by 285
“2 (58–69) ECOG PS, n (%) 0 10 (59) 1–2 7 (41) Smoking history, n (%) Never 1 (6) Former⁄current 16 (94) Histology, n (%) Adenocarcinoma 12 (70) Squamous cell carcinoma 3 (18) Other* 2 (12) Brain metastasis, n (%) Yes 3 (18) No 14 (82) KRAS mutation, n (%) Detected 6 (35) Not detected 11 (65) PD-L1 (IHC) tumor cells, n…”
Mgrditchian, T., Arakelian, T., Paggetti, J., Noman, M. Z., Viry, E., Moussay, E., Van Moer, K., Kreis, S., Guerin, C., Buart, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703921114 · Cited by 226
“As tumoral CCL5 has been described to recruit T cells (54) and macrophages (55) into the tumor bed as well, we cannot exclude that melanoma tumors expressing a high level of CCL5 are not only highly infiltrated by NK cells but also by T cells and macrophages.”
Background
Metadata
- Authors
- Liu, J., Li, F., Ping, Y., Wang, L., Chen, X., Wang, D., Cao, L., Zhao, S., Li, B., Kalinski, P., Thorne, S. H., Zhang, B., & Zhang, Y.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-07-16
- Volume
- 6
- Issue
- 28
- Pages
- 24978-24989
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1892403101
- Cited by
- 118
- References
- 6
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma. https://app.cochat.ai/papers/10.18632/oncotarget.4617
- The paper
- Liu, J., Li, F., Ping, Y., Wang, L., Chen, X., Wang, D., Cao, L., Zhao, S., Li, B., Kalinski, P., Thorne, S. H., Zhang, B., & Zhang, Y. (2015). Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma. Oncotarget. https://doi.org/10.18632/oncotarget.4617
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.